{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T21:25:17Z","timestamp":1792445117594,"version":"4.5.0"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,10]]},"abstract":"<jats:p>Epstein-Barr virus (EBV)-positive plasmacytoma is a rare plasma cell neoplasm. It remains unclear whether EBV-positive plasmacytoma represents a distinct entity or a variant of plasmacytoma. It shares morphologic features with plasmablastic lymphoma (PBL) and may cause diagnostic uncertainty. To better understand EBV-positive plasmacytoma and explore diagnostic criteria, this study describes 19 cases of EBV-positive plasmacytoma, compared with 27 cases of EBV-negative plasmacytoma and 48 cases of EBV-positive PBL. We reviewed the clinicopathologic findings and performed immunohistochemistry, in situ hybridization for EBV, fluorescence in situ hybridization for <jats:italic toggle=\"yes\">MYC<\/jats:italic>, and next-generation sequencing. We found that 63.2% of patients with EBV-positive plasmacytoma were immunocompromised. Anaplastic features were observed in 7\/19 cases. <jats:italic toggle=\"yes\">MYC<\/jats:italic> rearrangement was found in 25.0% of them, and extra copies of <jats:italic toggle=\"yes\">MYC<\/jats:italic> in 81.3%. EBV-positive and EBV-negative plasmacytomas possessed similar clinicopathologic features, except more frequent cytologic atypia, bone involvement and <jats:italic toggle=\"yes\">MYC<\/jats:italic> aberrations in the former group. The survival rate of patients with EBV-positive plasmacytoma was comparable to that of patients with EBV-negative plasmacytoma. In comparison to PBL, EBV-positive plasmacytoma is less commonly associated with a \u201cstarry-sky\u201d appearance, necrosis, absence of light chain expression, and a high Ki67 index (&gt;75%). The most recurrently mutated genes\/signaling pathways in EBV-positive plasmacytoma are epigenetic regulators, MAPK pathway, and DNA damage response, while the most frequently reported mutations in PBL are not observed. Collectively, EBV-positive plasmacytoma should be regarded as a biological variant of plasmacytoma. Thorough morphologic examination remains the cornerstone for distinguishing EBV-positive plasmacytoma and PBL, and molecular studies can be a valuable complementary tool.<\/jats:p>","DOI":"10.1097\/pas.0000000000001923","type":"journal-article","created":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T05:13:17Z","timestamp":1654146797000},"page":"1364-1379","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":17,"title":["Clinicopathologic and Molecular Characterization of Epstein-Barr Virus\u2013positive Plasmacytoma"],"prefix":"10.1097","volume":"46","author":[{"given":"Ting","family":"Zhou","sequence":"first","affiliation":[{"name":"Hematopathology Section"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinjun","family":"Cheng","sequence":"additional","affiliation":[{"name":"Hematopathology Section"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremiah","family":"Karrs","sequence":"additional","affiliation":[{"name":"Hematopathology Section"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa","family":"Davies-Hill","sequence":"additional","affiliation":[{"name":"Hematopathology Section"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana D.","family":"Pack","sequence":"additional","affiliation":[{"name":"Molecular Diagnostics and Bioinformatics, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqiang","family":"Xi","sequence":"additional","affiliation":[{"name":"Molecular Diagnostics and Bioinformatics, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoj","family":"Tyagi","sequence":"additional","affiliation":[{"name":"Molecular Diagnostics and Bioinformatics, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung","family":"Kim","sequence":"additional","affiliation":[{"name":"Molecular Diagnostics and Bioinformatics, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine S.","family":"Jaffe","sequence":"additional","affiliation":[{"name":"Hematopathology Section"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Raffeld","sequence":"additional","affiliation":[{"name":"Molecular Diagnostics and Bioinformatics, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Pittaluga","sequence":"additional","affiliation":[{"name":"Hematopathology Section"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,6,1]]},"reference":[{"key":"R3-20250608","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1097\/PAS.0b013e3181f3e29f","article-title":"IG\/MYC rearrangements are the main cytogenetic alteration in plasmablastic lymphomas","volume":"34","author":"Valera","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"R4-20250608","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.3324\/haematol.2020.251579","article-title":"Genetic lesions in MYC and STAT3 drive oncogenic transcription factor overexpression in plasmablastic lymphoma","volume":"106","author":"Garcia-Reyero","year":"2021","journal-title":"Haematologica"},{"key":"R5-20250608","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/modpathol.2016.162","article-title":"Plasmablastic lymphoma phenotype is determined by genetic alterations in MYC and PRDM1","volume":"30","author":"Montes-Moreno","year":"2017","journal-title":"Mod Pathol"},{"key":"R7-20250608","doi-asserted-by":"crossref","first-page":"5270","DOI":"10.1002\/cncr.27551","article-title":"Human immunodeficiency virus-associated plasmablastic lymphoma: poor prognosis in the era of highly active antiretroviral therapy","volume":"118","author":"Castillo","year":"2012","journal-title":"Cancer"},{"key":"R8-20250608","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/his.12640","article-title":"Epstein-Barr virus-positive plasmacytoma in immunocompetent patients","volume":"67","author":"Loghavi","year":"2015","journal-title":"Histopathology"},{"key":"R9-20250608","first-page":"582","article-title":"Epstein-Barr virus-positive plasmacytoma in immunocompetent patients: a diagnostic dilemma","volume":"13","author":"He","year":"2020","journal-title":"Int J Clin Exp Pathol"},{"key":"R10-20250608","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1182\/blood.V89.4.1413","article-title":"Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection","volume":"89","author":"Delecluse","year":"1997","journal-title":"Blood"},{"key":"R11-20250608","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.anndiagpath.2016.09.002","article-title":"Solitary plasmacytoma associated with Epstein-Barr virus: a clinicopathologic, cytogenetic study and literature review","volume":"27","author":"Yan","year":"2017","journal-title":"Ann Diagn Pathol"},{"key":"R12-20250608","first-page":"11073","article-title":"Low-grade Epstein-Barr virus positive plasma cell proliferations of precursor plasma cell origin: report of two cases","volume":"10","author":"Oaxaca","year":"2017","journal-title":"Int J Clin Exp Med"},{"key":"R13-20250608","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.yexmp.2010.10.007","article-title":"Plasmablastic lymphoma may occur as a high-grade transformation from plasmacytoma","volume":"90","author":"Qing","year":"2011","journal-title":"Exp Mol Pathol"},{"key":"R14-20250608","doi-asserted-by":"crossref","first-page":"49","DOI":"10.5045\/br.2020.55.1.49","article-title":"HIV-negative plasmablastic lymphoma: report of 8 cases and a comprehensive review of 394 published cases","volume":"55","author":"Li","year":"2020","journal-title":"Blood Res"},{"key":"R15-20250608","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1097\/01.pas.0000126781.87158.e3","article-title":"Diffuse large B-cell lymphomas with plasmablastic differentiation represent a heterogeneous group of disease entities","volume":"28","author":"Colomo","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"R16-20250608","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.3324\/haematol.2010.039214","article-title":"Plasmacytoma-like post-transplant lymphoproliferative disorder, a rare subtype of monomorphic B-cell post-transplant lymphoproliferation, is associated with a favorable outcome in localized as well as in advanced disease: a prospective analysis of 8 cases","volume":"96","author":"Trappe","year":"2011","journal-title":"Haematologica"},{"key":"R17-20250608","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1177\/1093526621999022","article-title":"EBV-positive plasmacytomas involving a nasopharyngeal angiofibroma in an adolescent","volume":"24","author":"Mariani","year":"2021","journal-title":"Pediatr Dev Pathol"},{"key":"R18-20250608","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1097\/PAS.0b013e3181f17d0d","article-title":"Nodal and extranodal plasmacytomas expressing immunoglobulin A: an indolent lymphoproliferative disorder with a low risk of clinical progression","volume":"34","author":"Shao","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"R19-20250608","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.3324\/haematol.2020.271957","article-title":"MAP-kinase and JAK-STAT pathways dysregulation in plasmablastic lymphoma","volume":"106","author":"Ramis-Zaldivar","year":"2021","journal-title":"Haematologica"},{"key":"R20-20250608","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12885-016-3015-5","article-title":"Solitary plasmacytoma: population-based analysis of survival trends and effect of various treatment modalities in the USA","volume":"17","author":"Thumallapally","year":"2017","journal-title":"BMC Cancer"},{"key":"R21-20250608","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1158\/2643-3230.BCD-20-0051","article-title":"Genomic characterization of HIV-associated plasmablastic lymphoma identifies pervasive mutations in the JAK-STAT pathway","volume":"1","author":"Liu","year":"2020","journal-title":"Blood Cancer Discov"},{"key":"R22-20250608","doi-asserted-by":"crossref","first-page":"5183","DOI":"10.1038\/s41467-021-25405-w","article-title":"Molecular and functional profiling identifies therapeutically targetable vulnerabilities in plasmablastic lymphoma","volume":"12","author":"Frontzek","year":"2021","journal-title":"Nat Commun"},{"key":"R23-20250608","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1309\/27H8XJH31F3GUNAT","article-title":"Plasmablastic cytomorphologic features in plasma cell neoplasms in immunocompetent patients are significantly associated with EBV","volume":"128","author":"Chang","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"R24-20250608","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s12105-011-0257-z","article-title":"EBV-positive plasmacytoma of the submandibular gland--report of a rare case with molecular genetic characterization","volume":"5","author":"Yan","year":"2011","journal-title":"Head Neck Pathol"},{"key":"R25-20250608","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/1024533031000153630","article-title":"Syndecan-1 in multiple myeloma: relationship to conventional prognostic factors","volume":"8","author":"Aref","year":"2003","journal-title":"Hematology"},{"key":"R26-20250608","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1038\/modpathol.3880435","article-title":"Syndecan-1 (CD138) immunoreactivity in bone marrow biopsies of multiple myeloma: shed syndecan-1 accumulates in fibrotic regions","volume":"14","author":"Bayer-Garner","year":"2001","journal-title":"Mod Pathol"},{"key":"R27-20250608","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/modpathol.2010.72","article-title":"Plasmablastic lymphoma with MYC translocation: evidence for a common pathway in the generation of plasmablastic features","volume":"23","author":"Taddesse-Heath","year":"2010","journal-title":"Mod Pathol"},{"key":"R29-20250608","doi-asserted-by":"crossref","first-page":"540","DOI":"10.7150\/thno.28374","article-title":"Comprehensive characterization of the mutational landscape in multiple myeloma cell lines reveals potential drivers and pathways associated with tumor progression and drug resistance","volume":"9","author":"Vikova","year":"2019","journal-title":"Theranostics"},{"key":"R30-20250608","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.cell.2015.04.045","article-title":"Alike but different: RAF paralogs and their signaling outputs","volume":"161","author":"Desideri","year":"2015","journal-title":"Cell"},{"key":"R31-20250608","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/sj.bjc.6605534","article-title":"Activating K-Ras mutations outwith \u2018hotspot\u2019 codons in sporadic colorectal tumours\u2014implications for personalised cancer medicine","volume":"102","author":"Smith","year":"2010","journal-title":"Br J Cancer"},{"key":"R32-20250608","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1750-2187-6-2","article-title":"Activation of K-RAS by co-mutation of codons 19 and 20 is transforming","volume":"6","author":"Naguib","year":"2011","journal-title":"J Mol Signal"},{"key":"R33-20250608","doi-asserted-by":"crossref","first-page":"e235","DOI":"10.3324\/haematol.2014.111872","article-title":"Plasmablastic transformation of a pre-existing plasmacytoma: a possible role for reactivation of Epstein Barr virus infection","volume":"99","author":"Ambrosio","year":"2014","journal-title":"Haematologica"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001923","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,8]],"date-time":"2025-06-08T21:02:02Z","timestamp":1749416522000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001923"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,1]]},"references-count":29,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000001923","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6,1]]}}}